(ACAS) American Capital announced a 17 million stock offering, 12 million of which are from the company and 5 million are from shareholders.
(ACLI) American Commercial Lines lowered guidance; announced a $200M share buyback plan.
(ASPM) Aspect Medical announced repurchase and alliance conclusion for brain monitoring products with Boston Scientific; ASPM will buy 2 million shares from BSX at $15.91/share; B
SX relieved of all obligations in alliance.
(ASYS) Amtech Systems reaches $16.5 Million in solar orders.
(BOT) CBOT buyout by CME received DOJ clearance.
(CRGN) Curagen announced positive data on for Belinostat in potential lymphoma treatment.
(DF) Dean Foods lowered its 2007 guidance to $1.52-1.58 EPS, down from $1.69.
(FNM) Fannie Mae noted as Cramer’s top pick right now for the changing political environment and ahead of getting its filings in order.
(FVRL) Favrille acquired Anti-CD20 monoclonal antibodies from Diversa.
(GERN) Geron released positive data on its telomerase inhibitor cancer drug in Phase I/II trial.
(HOFF) Horizon Offshore confirms it will be acquired by Cal-Dive for $19.25 per share.
(IDIX) Idenix Pharma announced 72% response rate for Hepatitis C treatment.
(INAP) Internap reaffirmed 2007 guidance after expanding collocation facilities.
(LEH) Lehman set to report earnings today, estimate is $1.88 EPS.
(STR) Questar trades ex-split to reflect a 2-1 stock split.
(TBUS) Digital Recorders said it is considering shareholder value enhancements.
(TLVT) Televent awarded contract worth close to $40 million.
(TTWO) Take-Two traded up 2% after earnings, no volume seen yet today.
(TXN) Texas Instruments lowered guidance at mid-quarter update.
(VICL) Vical received $6 Million grant from NIH to advance RapidResponse DNA vaccine platform
(VSEC) VSE Corp. trades ex-split to reflect a 2-1 stock split.
(YHOO) Yahoo! has its annual shareholder meeting today.